A gene encoding a carrier protein for glutamate and aspartate was cloned into Escherichia coli K-12 strain BK9MDG by using the high-copy-number plasmid pBR322. The gene (designated glP) is probably identical to a gene recently cloned from E. coli B (Y. Deguchi, I. Yamato, and Y. Anraku, J. Bacteriol. 171:1314-1319). A 1.6-kilobase DNA fragment containing glP was subcloned into the expression plasmids pT7-5 and pT7-6, and its product was identified by a phage T7 RNA polymerase-T7 promoter coupled system (S. Tabor and C. C. Richardson, Proc. Natl. Acad. Sci. USA 82:1074-1078) as a polypeptide with an apparent mass of 38 kilodaltons. A portion of the gltP polypeptide was associated with the cytoplasmic membrane. The nucleotide sequence of the 1.6-kilobase fragment was determined. It contained an open reading frame capable of encoding a highly hydrophobic polypeptide of 395 amino acids, containing four possible transmembrane segments. Uptake of glutamate and aspartate was increased 5.5-and 4.5-fold, respectively, in strains containing gltP plasmids. Glutamate uptake was insensitive to the concentration of Na+ and was inhibited by L-cysteate and (B-hydroxyaspartate. These results suggest that gltP is a structural gene for a carrier protein of the Na+-independent, binding-protein-independent glutamate-aspartate transport system. Escherichia coli K-12 strains generally do not grow well on L-glutamate as a sole source of carbon and energy, probably because the transport systems for glutamate are repressed in wild-type strains (11). Mutants with derepressed levels of glutamate uptake were isolated by selecting for sensitivity to toxic analogs of glutamate (6, 15) . Studies with these and other strains identified five systems for dicarboxylic amino acid transport in E. coli DW2 (15): (i) a binding-protein-independent, Na+-dependent, glutamatespecific system; (ii) a binding-protein-dependent, Na+-independent system for transport of glutamate and aspartate; (iii) a binding-protein-independent, Na+-independent glutamateaspartate system; (iv) a binding-protein-independent, aspartate-specific system; and (v) a dicarboxylic acid transport system that carries aspartate in addition to malate, fumarate, and succinate. Cloning of the genes encoding the various components of the glutamate-aspartate transport systems would provide a method for studying regulation of expression of the genes as well as the nature and function of the gene products.
Na+-independent, binding-protein-independent glutamate-aspartate transport system. Escherichia coli K-12 strains generally do not grow well on L-glutamate as a sole source of carbon and energy, probably because the transport systems for glutamate are repressed in wild-type strains (11) . Mutants with derepressed levels of glutamate uptake were isolated by selecting for sensitivity to toxic analogs of glutamate (6, 15) . Studies with these and other strains identified five systems for dicarboxylic amino acid transport in E. coli DW2 (15) : (i) a binding-protein-independent, Na+-dependent, glutamatespecific system; (ii) a binding-protein-dependent, Na+-independent system for transport of glutamate and aspartate; (iii) a binding-protein-independent, Na+-independent glutamateaspartate system; (iv) a binding-protein-independent, aspartate-specific system; and (v) a dicarboxylic acid transport system that carries aspartate in addition to malate, fumarate, and succinate. Cloning of the genes encoding the various components of the glutamate-aspartate transport systems would provide a method for studying regulation of expression of the genes as well as the nature and function of the gene products.
In a recent paper (4), the cloning of two E. coli B genes for glutamate and aspartate transport was described. One gene (gltS) specified a glutamate-specific, Na+-dependent carrier and corresponds to the E. coli K-12 gItS gene mapped at 82 min on the E. coli chromosome (11) . The other gene (gltP) specified a Na+-independent, glutamate-aspartate carrier. In this paper, we describe the cloning, expression, sequencing, and function of a gene for glutamate-aspartate transport. Since there are significant similarities between the properties of the gltP gene cloned by Deguchi et al. (4) and the gene described here, we also used the gene designation gltP.
MATERIALS AND METHODS
Bacterial strains, bacteriophages, and plasmids. E. coli K-12 strain BK9MDG [F-thi metC hsdS (r-m-) endB A(glnHPQ-chlE)], constructed as described previously (13) , * Corresponding author. was used throughout this study. Strain BJW1 was derived from BK9MDG by selecting for growth on glutamate. The plasmids used were pBR322, pT7-5, pT7-6, and pGPI-2. Nucleotide sequencing was performed by using phages M13mpl8 and M13mpl9.
Media. Strains were grown in either a rich medium (nutrient broth, medium 869, YT [containing, per liter of water, 8 g of Bacto-Tryptone {Difco Laboratories, Detroit, Mich.}, 5 g of yeast extract {Difco}, and 2.5 g of NaCl]) or medium E (17) supplemented with 40 ,uM thiamine HCI, 0.4 mM L-methionine, and 0.5% (wt/vol) D-glucose, L-glutamate, or glutamine. For uptake studies with whole cells and for the preparation of membrane vesicles, bacteria were grown in medium A (2) supplemented with 40 ,uM thiamine HCI, 0.4 mM L-methionine, 0.5% (wt/vol) L-glutamate, and 0.5% (wt/vol) sodium succinate. Antibiotics were used at the following concentrations: ampicillin, 35 p.g/ml: tetracycline, 15 ,ug/ml; kanamycin, 40 ,ug/ml, and rifampin, 200 p.g/ml. Solid medium contained 1.5% (wt/vol) Bacto-Agar (Difco rather than 5 min.
Determination of cellular location of gene products. Cells were incubated with [35S]methionine for either 2 or 20 min to label the plasmid-encoded proteins that were synthesized by the labeled cells as previously described (5), were examined by using sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis.
SDS-polyacrylamide gel electrophoresis. For SDS-polyacrylamide gel electrophoresis, the stacking gel contained 3% acrylamide-0.08% bisacrylamide in 0.12 M Tris hydrochloride (pH 6.8), and the separation gel contained 12% acrylamide-0.32% bisacrylamide in 0.375 M Tris hydrochloride (pH 8.8). Both gels contained SDS at 0.1%. Electrophoresis was at 30 mA in buffer consisting of 0.1 M Tris hydrochloride (pH 8.3), 0.28 M glycine, and 0.4% SDS and was run until the tracking dye was approximately 1 cm from the bottom of the gel (about 4 h). Samples were boiled for 3 min prior to application. A series of cross-linked cytochrome c proteins were used as molecular weight standards. Gels were stained with Coomassie brilliant blue, treated with enhancer (Dupont, New England Nuclear Research Products, Boston, Mass.), dried, and exposed to X-ray film for autoradiography.
DNA sequencing. Suitable restriction fragments were cloned into the phage vectors M13mpl8 and M13mp19, with E. coli JM107 as the host (19) . DNA sequencing was by the chain termination method (14) Uptake of glutamate and aspartate by whole cells. Cells from mid-exponential-phase cultures were harvested by centrifugation and then washed three times and suspended in 50 mM potassium phosphate buffer (pH 6.9) containing 0.5 mM MgSO4 (buffer A). The assay for uptake of glutamate and aspartate was performed essentially as described by Willis and Furlong (18) . The assay mixture contained cell suspension in buffer A (0.37 mg [dry weight] of bacteria per mI), 0.5% (wt/vol) D-glucose, 100 ,ug of chloramphenicol per ml, and 40 mM NaCl. Where applicable, inhibitors were added to the following concentrations; 24 mM L-cysteate, 34 mM methyl-DL-glutamate, 6.7 mM DL-threo-3-hydroxyaspartate. (9), with bovine serum albumin as the standard. Glutamate and aspartate transport by membrane vesicles. Assays of glutamate and aspartate transport by membrane vesicles were performed the same way as whole-cell uptake assays, with the exception that the assay mixture contained vesicles (1 mg of protein per ml), 40 mM NaCl, 20 mM D-lactate, 25 mM MgSO4, and 50 mM potassium phosphate buffer (pH 6.6). The filter membranes were washed with ice-cold potassium phosphate buffer (5 ml).
RESULTS
Isolation and characterization of a Glt+ (suppressed) strain. The host used for gene cloning was E. coli K-12 strain BK9MDG, which contains a deletion, extending from glnH to chlE (13) , that abolishes glutamine transport and growth (12) . If the inability of BK9MDG to grow on glutamate resulted from deficient transport of this substrate, then using BK9MDG as a host for cloning might allow for the selection of genes specifying glutamate carriers. Furthermore, investigation of the function of genes that reverse the Glt-phenotype of BK9MDG may provide some insight into the relationship between mutations at glnHPQ and the ability to use glutamate as a carbon and energy source.
When strain BK9MDG was plated on mineral salts agar containing glutamate as the sole carbon source, clones arose with a frequency of 10-9 to 10-1°, confirming an earlier observation of Masters and Hong (12) . These clones had not regained the ability to utilize glutamine and must have contained suppressor mutations that conferred the Glt+ phenotype. One of the clones, BJW1, that grew well on glutamate was chosen for further investigation.
The rates of uptake of glutamate and aspartate by strain BJW1 were found to be 3-and 1.4-fold, respectively, those of strain BK9MDG (Fig. 1) , suggesting that in the suppressed strain, a transport system for glutamate, and possi- (16 DNA fragments in the size range of 4 to 8 kilobases (kb) were isolated from low-melting-point agarose gels and purified by passing the samples through NACS. 52 2. An AvaI site that is situated 553 base pairs to the right of the BamHI site at 5.5 kb is not shown in Fig. 2 but was revealed at position 230 in the nucleotide sequence (see Fig.  6 ). The most significant sites for our purpose were the MluI and NsiI sites that flanked a 1.6-kb DNA fragment. The MluI-NsiI fragment was removed from pBW1, treated with S1 nuclease to produce blunt ends, and introduced into the SmaI site of pT7-6. The ligation mixture produced positive complementation (i.e., a Glt+ phenotype) when transformed into BK9MDG, suggesting that the gene responsible, gltP, was contained within the 1.6-kb DNA fragment. The Glt+ clones contained plasmids that were 3.8 kb in size. The insert DNA (1.6 kb) was removed from one of the plasmids (pBW8) by using the PstI and EcoRI sites of pT7-6 and, by using the same restriction sites, was introduced into pT7-5 in the orientation opposite to that of pBW8 to form pBW5. Characterization of the gene product of gltP. To determine the nature of the polypeptide product encoded by gltP, pBW8 and pBW5 were transformed (separately) into strain BK9MDG. pGPI-2 was then transformed into the strains containing either pBW8 or pBW5 by selecting the kanamycin resistance phenotype conferred by pGPI-2. The gene product(s) encoded by pBW8 and pBW5 was then identified by the phage T7 RNA polymerase-T7 promoter coupled system of Tabor and Richardson (16) . Under these conditions, pBW8 expressed a single polypeptide product with a molecular mass of approximately 38 kilodaltons (kDa) (Fig. 3) . No polypeptide products were formed from expression of pBW5, suggesting that gltP was transcribed in the direction NsiI to MluI. The 38-kDa polypeptide of pBW8 occurred in (Fig. 4) . Washing the membrane twice with 0.4 M NaCl did not remove the 38-kDa polypeptide.
Biochemical function of GltP. The rates of uptake of glutamate and aspartate by whole cells of strain BK9MDG containing the plasmid pBW8 (strain DLH1) were 5.5-and 4.5-fold, respectively, those of strain BK9MDG (Fig. 1) . In contrast to strain BK9MDG, the uptake of glutamate by strain DLH1 was almost completely inhibited by L-cysteate and by P-hydroxyaspartate but was insensitive to a-methylglutamate (Table 1 ) and was not inhibited by omission of Na+ from the reaction mixture (result not shown). When tested in transport assays, membrane vesicles prepared from strains DLH1 and BK9MDG gave results similar to those of the whole cells (Fig. 5) . Although the initial rate of aspartate uptake (to 90 s) by vesicles of DLH1 was severalfold that of BK9MDG vesicles, leakage of aspartate from vesicles of the former strain appeared to occur (Fig. SB) . The reason for the leakage of aspartate, but not glutamate, is unclear and should be investigated further. Uptake of glutamate in vesicles of DHL1 was inhibited only slightly when Na+ was omitted from the reaction mixture (result not shown).
Nucleotide sequence of the 1.6-kb DNA fragment containing gltP. The nucleotide sequence of the 1.6-kb NsiI-MluI fragment containing gltP was determined in both directions by the M13-dideoxynucleotide chain termination method (Fig.  6) Amino acid sequence and properties of GltP. Examination of the amino acid sequence of GltP inferred from the nucleotide sequence indicated that the polypeptide was extremely hydrophobic, since 63% of the total amino acid residues contained nonpolar side chains. GltP contains a total of 30 lysine-plus-arginine residues and 18 glutamic acid-plus-aspartic acid residues, suggesting a protein with an overall positive charge. The calculated molecular mass of 43.3 kDa for GltP is larger than its apparent molecular mass of 38 kDa determined by SDS-polyacrylamide gel electrophoresis. Such anomalous behavior can be attributed to the high degree of hydrophobicity of the protein and is characteristic of membrane transport proteins (1). Examination of GltP for potential transmembrane regions by the method of Kyte and Doolittle (8) indicated the presence of four such regions (Fig. 7) . The hydrophobic nature of GltP is consistent with its location in the cell membrane and its function as a transport protein.
DISCUSSION
The observation that a suppressor clone (strain BJW1), isolated by plating strain BK9MDG (A [glnHPQ]) to glutamate, contained elevated levels of glutamate and aspartate uptake compared with those of the parent strain (Fig. 1) indicates that the Glt-phenotype of BK9MDG can be reversed by increasing the level of glutamate transport. This was confirmed by the isolation of a clone of BK9MDG (strain DLH1) that contained a high-copy-number plasmid harboring a gene (gltP) encoding a glutamate-aspartate carrier protein. The reason for the Glt-phenotype of strain BK9MDG is unclear. The results might suggest that there is an interaction between the glutamine transport system and one or more of the transport systems for glutamate. Perhaps strain BK9MDG (and other glnH strains) fails to grow on glutamate because this interaction is destroyed by mutation, resulting in rates of transport that are insufficient for growth. It is difficult, however, to reconcile this interpretation with the observation that although BK9MDG has one-third the uptake rate for glutamate compared with BJW1, the latter strain grows well on glutamate, whereas the former does not. It is quite possible that the inability of glnHPQ mutants to grow on glutamate is only indirectly related to uptake.
The properties of the transport gene contained in plasmid pBW1 and of its gene product are sufficiently similar to those of a gene, gltP, cloned recently from E. coli B by Deguchi et al. (4) to lead us to believe that we cloned the same gene from E. coli K-12. The restriction map of the insert of pDEH17 (4) contains restriction sites for BamHI, BglII, and AvaI in almost the same positions as those of the insert of pBW1 ( Fig. 2 and 6 ). The molecular mass of the gene product expressed by pBW8 was 38 kDa, the same as that found for the gltP gene product of E. coli B (4). The gene product specified by pBW8 stimulated both glutamate and aspartate uptake in whole cells (Fig. 1 ) and membranous vesicles (Fig. 5) . The stimulated uptake was not Na+ dependent and was sensitive to inhibition by L-cysteate and P-hydroxyaspartate but not a-methylglutamate. These properties suggest that the gene described in this paper encodes a carrier that is part of the Na+-independent, bindingprotein-independent glutamate-aspartate transport system. The facts that this carrier is a hydrophobic protein with four possible transmembrane regions and that a considerable proportion of it was firmly bound in the membrane are consistent with a transport function. The observation (Fig. 4) that not all of it was found within the membrane fraction in strain DLH1 may be due to saturation of a limited number of membrane sites by GltP. There is some evidence to suggest that expression of gltP is repressed in E. coli K-12. When present in a highcopy-number plasmid, gltP complemented strain BK9MDG. However, in the mini-F plasmid (pMFC17) ( 
